Skip Nav Destination
Issues
1 September 2005
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Editorial
The Biology Behind
Perspective
Human Cancer Biology
Malignant B-Lymphoid Cells with Bone Lesions Express Receptor Activator of Nuclear Factor-κB Ligand and Vascular Endothelial Growth Factor to Enhance Osteoclastogenesis
Hironobu Shibata; Masahiro Abe; Kenji Hiura; Javier Wilde; Keiji Moriyama; Toshiaki Sano; Ken-ichi Kitazoe; Toshihiro Hashimoto; Shuji Ozaki; Shingo Wakatsuki; Shinsuke Kido; Daisuke Inoue; Toshio Matsumoto
Patterns of Gene Expression in Different Histotypes of Epithelial Ovarian Cancer Correlate with Those in Normal Fallopian Tube, Endometrium, and Colon
Rebecca T. Marquez; Keith A. Baggerly; Andrea P. Patterson; Jinsong Liu; Russell Broaddus; Michael Frumovitz; Edward N. Atkinson; David I. Smith; Lynn Hartmann; David Fishman; Andrew Berchuck; Regina Whitaker; David M. Gershenson; Gordon B. Mills; Robert C. Bast, Jr.; Karen H. Lu
Enhanced Production of Interleukin 6 in Peripheral Blood Monocytes Stimulated with Mucins Secreted into the Bloodstream
Norio Yokoigawa; Noriko Takeuchi; Munetoyo Toda; Mizue Inoue; Masaki Kaibori; Hidesuke Yanagida; Hironori Tanaka; Tokuhiro Ogura; Hideho Takada; Tadayoshi Okumura; A-H Kwon; Yasuo Kamiyama; Hiroshi Nakada
Estrogen Receptor α Binds to Peroxisome Proliferator–Activated Receptor Response Element and Negatively Interferes with Peroxisome Proliferator–Activated Receptor γ Signaling in Breast Cancer Cells
Daniela Bonofiglio; Sabrina Gabriele; Saveria Aquila; Stefania Catalano; Mariaelena Gentile; Emilia Middea; Francesca Giordano; Sebastiano Andò
Imaging, Diagnosis, Prognosis
Genetic Classification of Lung Adenocarcinoma Based on Array-Based Comparative Genomic Hybridization Analysis: Its Association with Clinicopathologic Features
Tatsuhiro Shibata; Satomi Uryu; Akiko Kokubu; Fumie Hosoda; Misao Ohki; Tokuki Sakiyama; Yoshihiro Matsuno; Ryosuke Tsuchiya; Yae Kanai; Tadashi Kondo; Issei Imoto; Johji Inazawa; Setsuo Hirohashi
Hepatocyte Growth Factor Promotes Cancer Cell Migration and Angiogenic Factors Expression: A Prognostic Marker of Human Esophageal Squamous Cell Carcinomas
Yi Ren; Brian Cao; Simon Law; Yi Xie; Ping Yin Lee; Leo Cheung; Yongxong Chen; Xin Huang; Hiu Man Chan; Ping Zhao; John Luk; George Vande Woude; John Wong
Cancer Therapy: Clinical
ERCC1 Codon 118 Polymorphism Is a Predictive Factor for the Tumor Response to Oxaliplatin/5-Fluorouracil Combination Chemotherapy in Patients with Advanced Colorectal Cancer
Jérôme Viguier; Valérie Boige; Catherine Miquel; Marc Pocard; Bruno Giraudeau; Jean-Christophe Sabourin; Michel Ducreux; Alain Sarasin; Françoise Praz
In vivo Generation of Angiostatin Isoforms by Administration of a Plasminogen Activator and a Free Sulfhydryl Donor: A Phase I Study of an Angiostatic Cocktail of Tissue Plasminogen Activator and Mesna
Gerald A. Soff; Hao Wang; Deborah L. Cundiff; Keyi Jiang; Brenda Martone; Alfred W. Rademaker; Jennifer A. Doll; Timothy M. Kuzel
Cancer Therapy: Preclinical
Inhibition of αvβ3 Integrin Survival Signaling Enhances Antiangiogenic and Antitumor Effects of Radiotherapy
Amir Abdollahi; David W. Griggs; Heike Zieher; Alexandra Roth; Kenneth E. Lipson; Rainer Saffrich; Hermann-Josef Gröne; Dennis E. Hallahan; Ralph A. Reisfeld; Juergen Debus; Andreas G. Niethammer; Peter E. Huber
Antiapoptotic Role of Growth Factors in the Myelodysplastic Syndromes: Concordance Between In vitro and In vivo Observations
Ramin Tehranchi; Bengt Fadeel; Jan Schmidt-Mende; Ann-Mari Forsblom; Emma Emanuelsson; Martin Jadersten; Birger Christensson; Robert Hast; Robert B. Howe; Jan Samuelsson; Boris Zhivotovsky; Eva Hellström-Lindberg
Gene Expression Profiles Associated with Response to Chemotherapy in Epithelial Ovarian Cancers
Amir A. Jazaeri; Christopher S. Awtrey; Gadisetti V.R. Chandramouli; Yao Eric Chuang; Javed Khan; Christos Sotiriou; Olga Aprelikova; Cindy J. Yee; Kristin K. Zorn; Michael J. Birrer; J. Carl Barrett; Jeff Boyd
Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo
Lifang Gao; Ling Zhang; Jiadi Hu; Feng Li; Yueting Shao; Dan Zhao; Dhananjaya V. Kalvakolanu; Dennis J. Kopecko; Xuejian Zhao; De-Qi Xu
Treatment of Human Tumor Xenografts with Monoclonal Antibody 806 in Combination with a Prototypical Epidermal Growth Factor Receptor–Specific Antibody Generates Enhanced Antitumor Activity
Rushika M. Perera; Yoshitaka Narita; Frank B. Furnari; Hui K. Gan; Carmel Murone; Marika Ahlkvist; Rodney B. Luwor; Antony W. Burgess; Elisabeth Stockert; Achim A. Jungbluth; Lloyd J. Old; Webster K. Cavenee; Andrew M. Scott; Terrance G. Johns
Expression of the Apoptosis Inhibitor Protease Inhibitor 9 Predicts Clinical Outcome in Vaccinated Patients with Stage III and IV Melanoma
Inge S. van Houdt; Joost J. Oudejans; Alfonsus J.M. van den Eertwegh; Arnold Baars; Wim Vos; Bellinda A. Bladergroen; Donata Rimoldi; Jettie J.F. Muris; Erik Hooijberg; Chad M. Gundy; Chris J.L.M. Meijer; Jean A. Kummer
Correction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds